Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
NCT: NCT07795593 · NOT_YET_RECRUITING
Brief Summary
The research team will perform a comparative-effectiveness sequential, multiple assignment, randomized trial in painful diabetic neuropathy (PDN) patients for 8 total months, divided into two 4-month stages. 600 participants 18+ with PDN will be enrolled in this study. The main goal is to compare the utility of three modalities (oral, topical, and behavioral) for initial PDN treatment, and to compare the utility of switching modalities versus continuing with the same modality for non-responders. Pain and discontinuation will be assessed weekly, whereas other outcomes will be assessed monthly for 8 months.
Frequently Asked Questions
What is Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy?
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy is a clinical trial registered under NCT07795593. Current status: NOT_YET_RECRUITING.
What is the status of NCT07795593?
The current status of NCT07795593 (Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy) is: NOT_YET_RECRUITING.
When did Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy start?
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.